M&A Deal Summary

Precigen Acquires Codexis Laboratories Hungary Kft.

On March 17, 2014, Precigen acquired life science company Codexis Laboratories Hungary Kft. from Codexis

Acquisition Highlights
  • This is Precigen’s 3rd transaction in the Life Science sector.
  • This is Precigen’s 1st transaction in Hungary.

M&A Deal Summary

Date 2014-03-17
Target Codexis Laboratories Hungary Kft.
Sector Life Science
Buyer(s) Precigen
Sellers(s) Codexis
Deal Type Divestiture

Target

Codexis Laboratories Hungary Kft.

Budapest, Hungary
Codexis Laboratories Hungary Kft. operates a biocatalysts research and development facility.

Search 215,058 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Precigen

Germantown, Maryland, United States

Category Company
Founded 1998
Sector Life Science
Employees143
Revenue 4M USD (2024)
DESCRIPTION

Precigen provides biologically based products and processes that improve the quality of life and health of the planet. The science underlying these products is known as synthetic biology – an engineered approach to the field of biology. Precigen was founded in 1998 and is based in Germantown, Maryland.


DEAL STATS #
Overall 3 of 10
Sector: Life Science M&A 3 of 9
Type: Divestiture M&A Deals 1 of 1
Country: Hungary M&A 1 of 1
Year: 2014 M&A 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-03-07 Medistem

San Diego, California, United States

Medistem, Inc. is a pioneer in the development of Endometrial Regenerative Cells ("ERC" or "ERCs"), universal donor adult-derived stem cells with properties uniquely suited for therapeutic use with Intrexon's existing suite of synthetic biology technologies.

Buy $26M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-07-01 Trans Ova Genetics LC

Sioux Center, Iowa, United States

Trans Ova Genetics LC is a provider of bovine reproductive technologies. Company Genetics provides industry-leading reproductive technologies and expertise to cattle breeders through a unique professional services team that works closely with clients to understand their breeding goals, and ultimately help clients advance and extend superior genetics.

Buy $60M

Seller(S) 1

SELLER

Codexis

Redwood City, California, United States

Category Company
Founded 2002
Sector Life Science
Employees188
Revenue 59M USD (2024)
DESCRIPTION

Codexis is a developer of biocatalysts or enzymes that initiate and accelerate a chemical reaction. Codexis' technologies bring improved manufacturing approaches to sectors ranging from the pharmaceutical industry, fine chemicals, flavors and fragrances, to animal health, food and nutrition, agrochemicals and carbon capture. Codexis was founded in 2002 and is based in Redwood City, California.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: Hungary M&A 1 of 1
Year: 2014 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-07-19 Biocatalytics

Pasadena, California, United States

Biocatalytics, Inc. is a private company that has produced custom and off-the-shelf enzymes used in chemical process manufacturing by pharmaceutical and fine chemical companies.

Buy -